Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “SPRUCE BIOSCIENCES, INC.”

9 pharma patents match "SPRUCE BIOSCIENCES, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 9
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 9 pharmaceutical patents matching "SPRUCE BIOSCIENCES, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

9 results for “SPRUCE BIOSCIENCES, INC.” · 30,257 patents in full index Clear search

  1. US 12115166

    Corticotropin releasing factor receptor antagonists

    SPRUCE BIOSCIENCES, INC. · Granted Oct 15, 2024 · Expires Oct 10, 2044

    granted
  2. US 12098152

    Methods and compositions for treating polycystic ovary syndrome

    SPRUCE BIOSCIENCES, INC. · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  3. US 11858932

    Methods and compositions for treating polycystic ovary syndrome

    SPRUCE BIOSCIENCES, INC. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  4. US 11351177

    Corticotropin releasing factor receptor antagonists

    SPRUCE BIOSCIENCES, INC. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  5. US 11344557

    Corticotropin releasing factor receptor antagonists

    SPRUCE BIOSCIENCES, INC. · Granted May 31, 2022 · Expires May 26, 2042

    granted
  6. US 11311549

    Corticotropin releasing factor receptor antagonists

    SPRUCE BIOSCIENCES, INC. · Granted Apr 26, 2022 · Expires Apr 21, 2042

    granted
  7. US 11304950

    Methods for treating testicular and ovarian adrenal rest tumors

    SPRUCE BIOSCIENCES, INC. · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  8. US 11007201

    Corticotropin releasing factor receptor antagonists

    SPRUCE BIOSCIENCES, INC. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  9. US 10849908

    Corticotropin releasing factor receptor antagonists

    SPRUCE BIOSCIENCES, INC. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted